Skip to main content
. Author manuscript; available in PMC: 2018 Jul 30.
Published in final edited form as: Cancer. 2018 May 30;124(14):2964–2973. doi: 10.1002/cncr.31543

Table 2.

Outcomes for screening strategies with similar age to start and age to stop screening as the selected benchmark colonoscopy strategy

Modality, and
Age to Start,
Age to End,
Interval (years)
Outcomes per 1000 40-year-olds
Efficiency
Ratiob
ER <
Benchmarkc
LYG >=
90% of
Benchmark
Model-
Recommended
Strategyd
No. of
Stool
tests
No. of
SIGs
No. of
CTCs
No. of
COLs
LYG Complications CRC
Deaths
Averteda
Colonoscopy
 COL 45-75-10e 0 0 0 5646 429 23 37 32 - - Yes

Stool tests
 FIT 45-75-3 8038 0 0 1619 310 11 27 5 Yes No

 FIT 45-75-2 10973 0 0 1994 352 13 30 9 Yes No

 HSgFOBT 45-75-3 7405 0 0 2024 310 13 27 Dom. - No

 FIT-DNA 45-75-5 4949 0 0 2157 333 14 29 Dom. - No

 HSgFOBT 45-75-2 9776 0 0 2516 354 15 30 Dom. - No

 FIT-DNA 45-75-3 6644 0 0 2640 376 16 32 Dom - No

 FIT 45-75-1 17835 0 0 2698 403 16 34 14 Yes Yes Yes

 HSgFOBT 45-75-1 14366 0 0 3364 403 18 34 Dom. - Yes

 FIT-DNA 45-75-1 12019 0 0 3851 426 19 36 50 No Yes
Flexible sigmoidoscopy
 SIG 45-75-10 0 2691 0 3314 373 19 33 9 Yes No

 SIG 45-75-5 0 3865 0 3761 403 20 35 15 Yes Yes Yes

CT colonography
 CTC 45-75-10 0 0 3045 2106 322 14 29 6 Yes No

 CTC 45-75-5 0 0 4630 2666 390 16 34 8 Yes Yes Yes

COL=colonoscopy, Dom.= Dominated, FIT= Fecal immunochemical test, HSgFOBT=High-sensitivity guaiac-based fecal occult blood test, FIT-DNA=Multitarget stool DNA test, SIG= Flexible sigmoidoscopy, CTC= Computed tomographic colonography, LYG= Life-years gained, CRC= Colorectal cancer, ER= Efficiency ratio

a

In the absence of screening, the model predicted 45 CRC Deaths.

b

calculated as incremental colonoscopies w.r.t.previous efficient strategyincremental LYG w.r.t.previous efficient strategy. It is an incremental burden-to-benefits ratio.

c

A strategy can only be recommended by the model if it has an efficiency ratio lower than the efficiency ratio of the benchmark strategy (colonoscopy every 10 years from ages 45 to 75 years).

d

A strategy is recommended by the model if it is an efficient or a near-efficient strategy with a lower burden-to-benefits ratio and at least 90% of the LYG compared to the benchmark strategy (colonoscopy screening every 10 years from ages 45 to 75 years).

e

This strategy was selected by the model when an efficiency ratio threshold of 40 or 45 incremental colonoscopies per LYG was applied.